OTCMKTS:MSACU Medicus Sciences Acquisition (MSACU) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free MSACU Stock Alerts $10.10 -0.16 (-1.56%) (As of 04/6/2021) Add Compare Share Share Today's Range$9.98▼$10.1050-Day Range$10.10▼$10.1052-Week Range$9.50▼$10.64Volume152,100 shsAverage Volume51,570 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Medicus Sciences Acquisition alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About Medicus Sciences AcquisitionMedicus Sciences Acquisition Corp. operates as blank check company targeting the medical technology sector. The company was incorporated in 2020 and is based in New York, New York.Read More MSACU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MSACU Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive MSACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicus Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:MSACU CUSIPN/A CIKN/A WebN/A Phone212 259 8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Jacob Jay Gottlieb C.F.A. (Age 49)CFA, M.D., Exec. Chairman Dr. Michael Bernard Castor M.D. (Age 49)CEO & Director Dr. Judah Zvi Drillick CPA (Age 44)Chief Financial Officer Mr. Eric B. Cheng (Age 51)Chief Bus. Officer Key Competitors10X Capital Venture AcquisitionOTCMKTS:VCVCU890 5th Avenue PartnersOTCMKTS:ENFAUACE Convergence AcquisitionOTCMKTS:ACEVUACON S2 AcquisitionOTCMKTS:STWOUAlpha Capital AcquisitionOTCMKTS:ASPCUView All Competitors MSACU Stock Analysis - Frequently Asked Questions How have MSACU shares performed in 2024? Medicus Sciences Acquisition's stock was trading at $10.10 at the beginning of the year. Since then, MSACU shares have increased by 0.0% and is now trading at $10.10. View the best growth stocks for 2024 here. How do I buy shares of Medicus Sciences Acquisition? Shares of MSACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MSACU) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.